CIK 0000882291
- Non-accelerated filer
- Smaller reporting company
AETHLON MEDICAL INC
Sign in to watch- Ticker
- AEMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 133632859
- Phone
- +1 619-941-0360
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA, 92121
- Former names
- BISHOP EQUITIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-10-20 | Shah Chetan Director | Returned to the company · Common Stock Purchase Warrant | −333,333 | 5,168,650 | ||
| 2014-10-20 | Shah Chetan Director | Grant or award · Common Stock Purchase Warrant | +333,333 | 5,501,983 | ||
| 2014-10-20 | Shah Chetan Director | Returned to the company · Common Stock Purchase Warrant | −1,111,111 | 4,390,872 | ||
| 2014-10-20 | Shah Chetan Director | Grant or award · Common Stock Purchase Warrant | +1,111,111 | 5,501,983 | ||
| 2014-07-24 | Shah Chetan Director | Grant or award | +2,503,966 | $0.09 | $220K | 11,253,966 |
| 2014-07-24 | Shah Chetan Director | Returned to the company · 10% Convertible Note | −220,349 | $220,349.00 | $48.6B | 0 |
| 2014-07-24 | Shah Chetan Director | Grant or award · Common Stock Purchase Warrant | +1,251,983 | 5,501,983 | ||
| 2014-06-06 | Tullis Richard VP, CHIEF SCIENCE OFFICER | Grant or award · Stock Options (right to buy) | +50,000 | 3,167,175 | ||
| 2014-06-06 | Shah Chetan Director | Grant or award · Stock Options (right to | +184,211 | 560,235 | ||
| 2014-06-06 | KENLEY RODNEY S PRESIDENT | Grant or award · Stock Options (right to buy) | +250,000 | 1,750,000 | ||
| 2014-06-06 | Joyce James A CHAIRMAN, CEO, SECRETARY | Grant or award · Stock Options (right to buy) | +1,500,000 | 15,588,243 | ||
| 2014-06-06 | FRAKES JAMES B CHIEF FINANCIAL OFFICER | Grant or award · Stock Options (right to buy) | +250,000 | 1,250,000 | ||
| 2014-06-06 | BROENNIMAN EDWARD G Director | Grant or award · Stock Options (right to buy) | +184,211 | 2,480,291 | ||
| 2014-06-06 | BARRY FRANKLYN S JR Director | Grant or award · Stock Options (right to buy) | +184,211 | 2,336,116 | ||
| 2014-03-14 | Ward Phillip A Former director | Grant or award · Stock Options (right to buy) | +182,927 | 555,953 | ||
| 2014-03-14 | Shah Chetan Director | Grant or award · Stock options (right to buy) | +376,024 | 376,024 | ||
| 2014-03-14 | BROENNIMAN EDWARD G Director | Grant or award · Stock options (right to buy) | +426,829 | 2,296,080 | ||
| 2014-03-14 | BARRY FRANKLYN S JR Director | Grant or award · Stock options (right to buy) | +426,829 | 2,151,908 | ||
| 2013-07-09 | Ward Phillip A Director | Grant or award · 10% Convertible Note | +0 | $200,000.00 | $0 | |
| 2013-07-01 | Tullis Richard VP, Chief Science Officer | Grant or award · Stock options (right to buy) | +500,000 | 3,117,175 |
Page 14 of 18 · 360 trades